Good morning Monday!

Let me open with a confession I’ve never put in writing.

For almost seven years, I traded manually. Commodities first (gold was my first love, and still is), then mostly FX, through prop firms.

The final scoreboard after all those years? Break-even. Roughly what I put in is what I took out.

I didn’t lose much money. I lost something more expensive: thousands of hours spent learning what it means to be a professional trader, without ever quite becoming one. Thats literally me.

I’ve seen everything this game can show you. Extraordinary winning streaks where you think you’ve cracked the code. Consistent months, then one afternoon that gives it all back. Nights when you’re convinced you’re the worst trader alive (I used much stronger words at the time). I have cried, have celebrated large checks with champagne.

The full catalogue.

Last year I stopped. Not quit, but paused. Trading done properly eats your entire life. If you’re a trader, trading is all you think about, and there’s no room for anything else. I still love the game, and I could talk about it forever.

So why am I telling you this now?

Because after hundreds of conversations with allocators and teams across the globe, I’ve realized something that took me embarrassingly long to see:

Allocating to quant strategies is just discretionary trading with better branding and larger checks.

The team’s strategy is coded. Your decision to allocate to it is not.

Discretionary means you have the freedom to act on what you believe your edge is, based on how you think the market works. And nobody puts on a trade thinking it’s a coin flip. Every entry rests on experience, a thesis, a story you believe. You only pull the trigger once you’re convinced this is the winning trade.

Allocation works exactly the same way. When you sign the SMA, some part of you believes you’ve found the strategy that won’t break. Nobody wires a seven-figure ticket thinking “this’ll probably be fine-ish.”

That conviction is both the fuel and the problem.

And every cycle brings the new arrivals, the ones who are certain they’re the special ones and know exactly how to do it. I was that guy in FX. The market humbled me. It humbles everyone. Humbling people is, quite literally, its job.

If you are still here, there is 100% chance you have had a humbling experience from financial markets.

Here’s the idea I’ve been sitting on for months.

Thought experiment. You’ve found 15 teams. You did proper due diligence. You allocate $1M across four of them and keep the other eleven on monitoring. Assume your picks are good. They fit your thesis.

Now count how many different years are hiding inside that one decision.

Nearly 1.8 million distinct portfolios. Same fifteen names. Same due diligence. And you haven’t made a single exit decision yet.

Add monthly decisions to cut, scale, or rotate over twelve months, and the number stops being a number.

That’s variation, visualised.
It’s the most important thing I want you to take from this edition.

Here’s how one of those 1.8 million paths plays out. I watch it happen constantly.

Two of your four teams are working. Two aren’t. Meanwhile, three of the eleven you passed on are ripping.

So you do the “rational” thing. You cut the two laggards and rotate into the hot ones.

Within weeks, the new teams cool off. Your original winners hit a soft patch. And the two teams you cut start recovering, for somebody else’s portfolio.

You didn’t do anything stupid. Every single decision was defensible on its own. And you’re down on the year.

That’s chasing rabbits. Every rabbit is real. The chase is what costs you.

If you’ve been reading this newsletter for a while, you’ll remember the allocators cutting 50% of their non-performing teams in one sweep. Some of those cuts were right. Some of them were rabbit chases, and we won’t know which until the paths play out.

From an allocator’s seat, five levers generate almost all of that variation.

01 — Timing: how you scale in and out.
Lump sum or four equal weekly tranches? This one lever alone would have prevented a large share of the impulsive decisions I’ve witnessed this year. The lump sum lands, the team has a normal drawdown in week two, and suddenly the allocator is staring at -8% on the full ticket and making decisions from the stomach. With tranches, that same week-two drawdown is just a better entry for tranche three. Same team, same month, completely different emotional experience, and very often a completely different decision.

02 — Selection: keeping what works, dumping what doesn’t.
The hardest skill in trading is telling a losing trade from a wrong trade. Allocation has the exact same problem: is this team in a normal drawdown, or is its edge decaying? Those two situations look identical on a monthly report and require opposite actions.

03 — Entries and exits: moving from test account to scale, and leaving.
I see allocators exit teams at the exact bottom with almost surgical precision. I can say just based by that when the bottom is in in a certain strategy. And I cant advise on this, because I do not know either.
The same psychology applies - its universal across trading.

04 — Waiting for the setup.
Refuse to touch anything less than an A+ team that ticks every box on your checklist, and in the meantime, do absolutely nothing. Doing nothing is a position. In my FX years, my best months were the ones where I traded least. My worst were boredom trades. Allocators have boredom allocations, and they cost exactly the same.

05 — Protecting your psychology.
In this game you can win big. But string a few mistakes together and you start doubting everything: the industry, the time horizon, your ability to generate yield when the market is ugly. And the market is ugly right now. BTC sits in the low 80s, roughly a third below last October’s all-time high around $126K. This is exactly the environment where yesterday’s mistake tries to vote on today’s decision. Don’t give it a vote.

Five levers, multiplied across every opportunity you’ll see this year. That’s variation. Much more actually, but these came first to mind.

Here’s where I’ll lose some of you.

If two allocators run identical due diligence on identical teams and finish the year 30 points apart, which one was skilled?

Maybe neither. Maybe the winner just landed on a path that never forced him to make a decision while in pain.

The uncomfortable implication: a big part of what this industry calls “manager selection skill” is actually variation management, and most allocators are measuring the wrong thing.

You can’t choose which of the 1.8 million paths you land on. You can reduce how many of them involve you acting on impulse.

That’s the real job. A good process doesn’t guarantee the best path. It cuts off the worst ones.

For teams, the picture is different. The code is the code. You can’t tranche your way out of a broken edge.

The one lever you do have is adaptation: seeing where the market is going before it gets there. And without overexplaining it, the direction is obvious. RWAs. Tokenized stocks. TradFi moving on-chain.

The numbers are getting hard to ignore. Tokenized stocks did over $15B of spot volume in Q1 2026 alone, more than the entire second half of 2025. RWA perpetuals traded north of $500B in the same quarter, against roughly $33B of underlying spot value. And the DTCC, which settles nearly every US equity trade, has slated its full tokenized-securities platform for this month.

That’s plumbing. When the plumbing changes, microstructure changes. And microstructure is where quant edges live.

My friendly advice: look at this asset class now. Itt’s early, and inefficiencies are loudest at the beginning. Its kinda similar to stage to what Polymarket was few years ago.

I had a long conversation recently with a founder trying to sell a service to SMA teams. Good guy, genuinely good product. We both enjoyed the call.

But it’s a vitamin, not a painkiller.

In this market, most SMA teams (and we speak to them directly, at scale) won’t even take that call. Not because they’re rude. Because, to put it politely, most of them are broke right now. They have exactly one pain point, and it’s making money and feeding their families in an uncertain market that favors noone.

Selling vitamins to teams right now is like selling ice to a penguin.

This applies to every business, not just quant: you make money by solving real problems at scale. If you’re not, you won’t have too many sales unless your marketing is real gem. That’s pretty much it.

Timing matters too. When the market turns, the same teams that ignore you today will happily budget for nice-to-haves. Until then, either reposition your product as a painkiller with a direct line to PnL, capital, or cost, or wait.

November starts next week. The second half of December will be dead. We all know this.

That leaves roughly seven real working weeks in 2026. If you’re raising, allocating, or selling, whatever doesn’t move before mid-December will most likely roll into mid-January. Plan backwards from that.

I never became a professional trader. But seven years taught me the one lesson that transfers perfectly to allocating:

The market doesn’t pay you for being right. It pays you for surviving long enough to be right repeatedly.

If you know an allocator who rotated into last quarter’s winner this month, forward this to them. They’ll thank you in Q1.

If you’re an allocator looking for teams, or a team looking for the right allocator universe, reach out at [email protected]. And if you can connect us with a team or an allocator, ask us about the referral.

Stay patient. Stay honest. Stay alive.

See you next week.

Quants.Space is an institutional discovery engine for systematic and discretionary trading strategies — 130+ independent, world-class quantitative and discretionary trading teams, each with vetted track records and unique alpha sources, plus a dedicated Emerging Managers sector for early-stage teams. Our mission is simple: connect institutional capital and allocators directly with best-in-class teams, all within a secure Separately Managed Account (SMA) framework. If you’re an allocator active in the SMA space, or a team opening SMA capacity for institutional tickets, get in touch at [email protected].